169 related articles for article (PubMed ID: 34952984)
1. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients.
Yan J; Wan D
J Clin Lab Anal; 2022 Feb; 36(2):e24140. PubMed ID: 34952984
[TBL] [Abstract][Full Text] [Related]
2. Circular RNA_0001946 is insufficiently expressed in tumor tissues, while its higher expression correlates with less lymph node metastasis, lower TNM stage, and improved prognosis in NSCLC patients.
Zhang M; Wen F; Zhao K
J Clin Lab Anal; 2021 Aug; 35(8):e23625. PubMed ID: 34216509
[TBL] [Abstract][Full Text] [Related]
3. Dysregulated transient receptor potential channel 1 expression and its correlation with clinical features and survival profile in surgical non-small-cell lung cancer patients.
Ke C; Long S
J Clin Lab Anal; 2022 Mar; 36(3):e24229. PubMed ID: 35106847
[TBL] [Abstract][Full Text] [Related]
4. Blood regulator of G protein signalling 1 as a potential prognostic biomarker in surgical nonsmall cell lung cancer patients: Correlation with clinical features and survival.
Wang L; Zhang H; Gu X; Wang Y
Clin Respir J; 2024 Jan; 18(1):e13712. PubMed ID: 38081176
[TBL] [Abstract][Full Text] [Related]
5. Katanin P80 correlates with larger tumor size, lymph node metastasis, and advanced TNM stage and predicts poor prognosis in non-small-cell lung cancer patients.
Ye Q; Zhang M; Yin Y
J Clin Lab Anal; 2020 Apr; 34(4):e23141. PubMed ID: 31944409
[TBL] [Abstract][Full Text] [Related]
6. The relation of blood cell division control protein 42 level with disease risk, comorbidity, tumor features/markers, and prognosis in colorectal cancer patients.
Gao S; Xue J; Wu X; Zhong T; Zhang Y; Li S
J Clin Lab Anal; 2022 Jul; 36(7):e24572. PubMed ID: 35735582
[TBL] [Abstract][Full Text] [Related]
7. AKIP1 expression in tumor tissue as a new biomarker for disease monitoring and prognosis in non-small cell lung cancer: Results of a retrospective study.
Liu Y; Tian J; Qin D; Liu J; Xie Y
J Clin Lab Anal; 2020 Apr; 34(4):e23128. PubMed ID: 31782840
[TBL] [Abstract][Full Text] [Related]
8. A-kinase-interacting protein 1 overexpression correlates with deteriorative tumor features and worse survival profiles, and promotes cell proliferation but represses apoptosis in non-small-cell lung cancer.
Chen H; Yan S; Dong L; Li X
J Clin Lab Anal; 2020 Feb; 34(2):e23061. PubMed ID: 31828834
[TBL] [Abstract][Full Text] [Related]
9. High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients.
Lou N; Zhu T; Qin D; Tian J; Liu J
Ir J Med Sci; 2022 Feb; 191(1):155-162. PubMed ID: 33635447
[TBL] [Abstract][Full Text] [Related]
10. LUNX mRNA-positive cells at different time points predict prognosis in patients with surgically resected nonsmall cell lung cancer.
Li J; Shi SB; Shi WL; Wang Y; Yu LC; Zhu LR; Ge LP
Transl Res; 2014 Jan; 163(1):27-35. PubMed ID: 24120632
[TBL] [Abstract][Full Text] [Related]
11. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
Yan B; Zhang W; Mao XW; Jiang LY
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
[TBL] [Abstract][Full Text] [Related]
12. Potentiality of forkhead box Q1 as a biomarker for monitoring tumor features and predicting prognosis in non-small cell lung cancer.
Li L; Xu B; Zhang H; Wu J; Song Q; Yu J
J Clin Lab Anal; 2020 Jan; 34(1):e23031. PubMed ID: 31713908
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic features and prognostic implications of Gankyrin protein expression in non-small cell lung cancer.
Wang WP; Yan XL; Li WM; Ni YF; Zhao JB; Lu Q; Wang XJ; Sun Y; Chen P; Yan BY; Cui Y; Zhang ZP; Li XF
Pathol Res Pract; 2015 Dec; 211(12):939-47. PubMed ID: 26554593
[TBL] [Abstract][Full Text] [Related]
14. GIT1 promotes lung cancer cell metastasis through modulating Rac1/Cdc42 activity and is associated with poor prognosis.
Chang JS; Su CY; Yu WH; Lee WJ; Liu YP; Lai TC; Jan YH; Yang YF; Shen CN; Shew JY; Lu J; Yang CJ; Huang MS; Lu PJ; Lin YF; Kuo ML; Hua KT; Hsiao M
Oncotarget; 2015 Nov; 6(34):36278-91. PubMed ID: 26462147
[TBL] [Abstract][Full Text] [Related]
15. High circulating miR-18a, miR-20a, and miR-92a expression correlates with poor prognosis in patients with non-small cell lung cancer.
Xu X; Zhu S; Tao Z; Ye S
Cancer Med; 2018 Jan; 7(1):21-31. PubMed ID: 29266846
[TBL] [Abstract][Full Text] [Related]
16. Protein Kinase D1 Is Increased in Tumor Tissue, Correlates With Advanced Tumor Features and Worse Prognosis of Non-Small Cell Lung Cancer.
Yao J; Jiang Y; Geng S; Sun L
Technol Cancer Res Treat; 2020; 19():1533033820934129. PubMed ID: 32985371
[TBL] [Abstract][Full Text] [Related]
17. Value of circular RNA 0007385 in disease monitoring and prognosis estimation in non-small-cell lung cancer patients.
Lin Y; Su W; Lan G
J Clin Lab Anal; 2020 Aug; 34(8):e23338. PubMed ID: 32666646
[TBL] [Abstract][Full Text] [Related]
18. Polo-like kinase 4 correlates with greater tumor size, lymph node metastasis and confers poor survival in non-small cell lung cancer.
Zhou Q; Fan G; Dong Y
J Clin Lab Anal; 2020 Apr; 34(4):e23152. PubMed ID: 31876063
[TBL] [Abstract][Full Text] [Related]
19. Chaperonin-containing tailless complex polypeptide 1 subunit 6A links with aggravating tumor features and disease-free survival in surgical gastric cancer patients: A long-term follow-up study.
He T; Yu D; Wang Z; Guo C; Chang Y; Wang D
Clin Res Hepatol Gastroenterol; 2022; 46(7):101913. PubMed ID: 35346891
[TBL] [Abstract][Full Text] [Related]
20. MACC1 overexpression predicts a poor prognosis for non-small cell lung cancer.
Wang Z; Li Z; Wu C; Wang Y; Xia Y; Chen L; Zhu Q; Chen Y
Med Oncol; 2014 Jan; 31(1):790. PubMed ID: 24310811
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]